Healthcare company-building profile
Y Combinator (biotech and healthcare)
Y Combinator
AcceleratorIndependent acceleratorIndependentActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Independent accelerator
- Organization
- Y Combinator
- Organization type
- Independent
- Location
- San Francisco, California
- Company stage served
- Early stage
- Cohort or participation model
- Batch-based accelerator, two or more batches per year, ending in Demo Day
- Investment or funding offered
- Yes
- Published investment terms
- YC standard deal: $500,000 total, structured as $125,000 for 7% plus $375,000 on an uncapped MFN SAFE
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2005
Public description
About the program
Y Combinator funds biotech, therapeutics and healthcare startups within its general batches and previously ran a dedicated YC Bio track with larger checks for early-stage life science teams. Companies join a batch, receive the YC standard deal, and pitch at Demo Day. YC named Surbhi Sarna its first partner dedicated to healthcare and biotech in 2021.
What the program publicly emphasizes
Focus areas and features
BiotechTherapeuticsHealthcareDiagnosticsMedical devices
- Category: Independent accelerator
- Program structure: Batch-based accelerator, two or more batches per year, ending in Demo Day
- Published terms: YC standard deal: $500,000 total, structured as $125,000 for 7% plus $375,000 on an uncapped MFN SAFE
Publicly documented people and network
Program leadership and alumni
- Notable alumni named in public materials
- Ginkgo Bioworks; Athelas
Sources
External source links open in a new tab.